Medtronic EBIT Margin 2010-2025 | MDT
Current and historical EBIT (Earnings Before Interest & Taxes) margin for Medtronic (MDT) over the last 10 years. The current EBIT profit margin for Medtronic as of April 30, 2025 is .
| Medtronic EBIT Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBIT | EBIT Margin |
| 2025-04-30 | $33.54B | $5.96B | 17.76% |
| 2025-01-31 | $33.20B | $5.57B | 16.78% |
| 2024-10-31 | $33.00B | $5.41B | 16.40% |
| 2024-07-31 | $32.58B | $5.16B | 15.83% |
| 2024-04-30 | $32.36B | $5.15B | 15.90% |
| 2024-01-31 | $32.32B | $5.66B | 17.51% |
| 2023-10-31 | $31.96B | $5.57B | 17.42% |
| 2023-07-31 | $31.56B | $5.63B | 17.84% |
| 2023-04-30 | $31.23B | $5.49B | 17.56% |
| 2023-01-31 | $30.77B | $5.59B | 18.17% |
| 2022-10-31 | $30.81B | $5.86B | 19.01% |
| 2022-07-31 | $31.07B | $6.02B | 19.37% |
| 2022-04-30 | $31.69B | $5.75B | 18.16% |
| 2022-01-31 | $31.79B | $5.69B | 17.89% |
| 2021-10-31 | $31.80B | $5.30B | 16.68% |
| 2021-07-31 | $31.60B | $4.67B | 14.78% |
| 2021-04-30 | $30.12B | $4.48B | 14.89% |
| 2021-01-31 | $27.93B | $3.20B | 11.44% |
| 2020-10-31 | $27.87B | $3.56B | 12.77% |
| 2020-07-31 | $27.93B | $3.98B | 14.25% |
| 2020-04-30 | $28.91B | $4.79B | 16.57% |
| 2020-01-31 | $31.06B | $6.42B | 20.67% |
| 2019-10-31 | $30.89B | $6.32B | 20.47% |
| 2019-07-31 | $30.67B | $6.52B | 21.25% |
| 2019-04-30 | $30.56B | $6.27B | 20.51% |
| 2019-01-31 | $30.56B | $6.25B | 20.45% |
| 2018-10-31 | $30.38B | $6.14B | 20.23% |
| 2018-07-31 | $29.95B | $6.49B | 21.68% |
| 2018-04-30 | $29.95B | $6.64B | 22.17% |
| 2018-01-31 | $29.73B | $6.40B | 21.52% |
| 2017-10-31 | $29.64B | $6.11B | 20.60% |
| 2017-07-31 | $29.93B | $5.60B | 18.70% |
| 2017-04-30 | $29.71B | $5.38B | 18.12% |
| 2017-01-31 | $29.36B | $5.27B | 17.96% |
| 2016-10-31 | $29.01B | $5.48B | 18.90% |
| 2016-07-31 | $28.73B | $5.40B | 18.79% |
| 2016-04-30 | $28.83B | $5.36B | 18.59% |
| 2016-01-31 | $28.57B | $3.95B | 13.81% |
| 2015-10-31 | $25.95B | $3.87B | 14.89% |
| 2015-07-31 | $23.26B | $3.76B | 16.16% |
| 2015-04-30 | $20.26B | $3.77B | 18.59% |
| 2015-01-31 | $17.52B | $3.91B | 22.33% |
| 2014-10-31 | $17.37B | $3.66B | 21.09% |
| 2014-07-31 | $17.20B | $3.68B | 21.37% |
| 2014-04-30 | $17.01B | $3.81B | 22.42% |
| 2014-01-31 | $16.90B | $4.70B | 27.80% |
| 2013-10-31 | $16.76B | $4.89B | 29.18% |
| 2013-07-31 | $16.67B | $4.87B | 29.23% |
| 2013-04-30 | $16.59B | $4.76B | 28.66% |
| 2013-01-31 | $16.43B | $4.78B | 29.09% |
| 2012-10-31 | $16.32B | $4.71B | 28.89% |
| 2012-07-31 | $16.25B | $4.75B | 29.23% |
| 2012-04-30 | $16.18B | $4.75B | 29.34% |
| 2012-01-31 | $15.86B | $4.52B | 28.46% |
| 2011-10-31 | $15.80B | $4.51B | 28.54% |
| 2011-07-31 | $15.68B | $4.38B | 27.91% |
| 2011-04-30 | $15.51B | $4.30B | 27.71% |
| 2011-01-31 | $15.30B | $4.37B | 28.56% |
| 2010-10-31 | $15.30B | $4.49B | 29.36% |
| 2010-07-31 | $15.23B | $4.63B | 30.37% |
| 2010-04-30 | $15.39B | $4.71B | 30.63% |
| 2010-01-31 | $15.45B | $4.32B | 27.95% |
| 2009-10-31 | $15.09B | $4.03B | 26.71% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $113.223B | $33.537B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.329B | 28.06 |
| Boston Scientific (BSX) | United States | $153.315B | 38.38 |
| Stryker (SYK) | United States | $149.550B | 31.27 |
| EssilorLuxottica (ESLOY) | France | $129.320B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.710B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.111B | 26.31 |
| ResMed (RMD) | United States | $37.519B | 28.18 |
| GE HealthCare Technologies (GEHC) | United States | $34.854B | 16.55 |
| Agilent Technologies (A) | United States | $34.275B | 22.34 |
| Terumo (TRUMY) | Japan | $25.791B | 33.50 |
| Koninklijke Philips (PHG) | Netherlands | $23.611B | 16.57 |
| Insulet (PODD) | United States | $21.226B | 83.32 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.499B | 11.88 |
| Baxter (BAX) | United States | $15.975B | 11.93 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.209B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.821B | 23.74 |
| Lantheus Holdings (LNTH) | United States | $5.509B | 13.90 |
| Prestige Consumer Healthcare (PBH) | United States | $3.962B | 17.70 |
| Perrigo (PRGO) | Ireland | $3.748B | 9.50 |
| Haemonetics (HAE) | United States | $3.663B | 16.68 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.419B | 28.41 |
| ICU Medical (ICUI) | United States | $3.352B | 24.72 |
| QuidelOrtho (QDEL) | United States | $2.041B | 14.04 |
| LeMaitre Vascular (LMAT) | United States | $1.894B | 42.35 |
| AtriCure (ATRC) | United States | $1.554B | 0.00 |
| Acuren (TIC) | United States | $1.375B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.264B | 12.84 |
| Green Thumb Industries (GTBIF) | United States | $1.169B | 26.29 |
| Neogen (NEOG) | United States | $1.135B | 14.53 |
| Phibro Animal Health (PAHC) | United States | $1.133B | 14.48 |
| BioLife Solutions (BLFS) | United States | $1.081B | 0.00 |
| InMode (INMD) | Israel | $0.961B | 9.69 |
| Kestra Medical Technologies (KMTS) | United States | $0.783B | 0.00 |
| Owens & Minor (OMI) | United States | $0.718B | 5.96 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.675B | 0.00 |
| CeriBell (CBLL) | United States | $0.673B | 0.00 |
| Evolus (EOLS) | United States | $0.594B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.551B | 0.00 |
| Valneva SE (VALN) | France | $0.494B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.488B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.458B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.359B | 13.21 |
| Quanterix (QTRX) | United States | $0.346B | 0.00 |
| SNDL (SNDL) | Canada | $0.328B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Cerus (CERS) | United States | $0.298B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.280B | 23.60 |
| ZimVie (ZIMV) | United States | $0.279B | 12.67 |
| Sanuwave Health (SNWV) | United States | $0.271B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.266B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.251B | 74.50 |
| Cresco Labs (CRLBF) | United States | $0.251B | 0.00 |
| Brainsway (BWAY) | Israel | $0.242B | 64.00 |
| Biote (BTMD) | United States | $0.229B | 6.45 |
| OraSure Technologies (OSUR) | United States | $0.229B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.219B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.187B | 15.21 |
| TriSalus Life Sciences (TLSI) | United States | $0.185B | 0.00 |
| Organigram Global (OGI) | Canada | $0.185B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.182B | 0.00 |
| Omeros (OMER) | United States | $0.181B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.150B | 0.00 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.128B | 15.73 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 12.33 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| MacroGenics (MGNX) | United States | $0.087B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.086B | 0.00 |
| Veru (VERU) | United States | $0.086B | 0.00 |
| Zynex (ZYXI) | United States | $0.081B | 0.00 |
| Apyx Medical (APYX) | United States | $0.081B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.077B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.060B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Nephros (NEPH) | United States | $0.042B | 56.86 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.81 |
| Safety Shot (SHOT) | United States | $0.030B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |